Amgen (AMGN) closed at $328.35 on Friday, 2.29% higher on the day. Amgen's stock price has increased 14.00% so far this year, ...

The Dow Jones Industrial Average and the other major stock indexes traded lower Friday as investors reacted to more inflation ...

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

Somerset Trust Co trimmed its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.6% in the third quarter, according to its ...

The offering will fund testing of a potential rival to Amgen’s Tezspire and is already the sixth for an immune drug developer this year, the most since 2021.

The investment community will be closely monitoring the performance of Amgen in its forthcoming earnings report. The company is scheduled to release its earnings on October 30, 2024. It is anticipated ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines Agency (EM ...

WealthCare Investment Partners LLC trimmed its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.6% in the ...

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are impairing lung function and contributing to ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: 8TV) a generative AI software leader in clinical trial analytics, is pleased to announce the appointment ...

The global anti-osteoporosis therapy and fracture healing market is poised for remarkable growth, with projections indicating a rise from USD 14,051.6 million in 2023 to USD 22,427.6 million by 2033, ...

On Monday, Amgen Inc (AMGN) stock saw a decline, ending the day at $317.45 which represents a decrease of $-2.21 or -0.69% from the prior close of $319.66. The stock opened at $320.08 and touched a ...